Veterinary Medicines

VACCINE AGAINST ANTHRAX

Authorised
  • Bacillus anthracis, strain Sterne 34F2, Live
Download as PDF

Product identification

Medicine name:
ВАКСИНА ПРОТИВ АНТРАКС
VACCINE AGAINST ANTHRAX
Active substance:
  • Bacillus anthracis, strain Sterne 34F2, Live
Target species:
  • Horse
  • Donkey
  • Camel
  • Cattle
  • Buffalo
  • Sheep
  • Goat
  • Pig
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bacillus anthracis, strain Sterne 34F2, Live
    7.00
    log10 colour changing units
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Horse
      • Meat and offal
        15
        day
    • Donkey
    • Camel
    • Cattle
      • Meat and offal
        15
        day
    • Buffalo
      • Meat and offal
        15
        day
    • Sheep
      • Meat
        15
        LD100 concentration for mice after i.m. injection after 5 days
    • Goat
      • Meat and offal
        15
        day
    • Pig
      • Meat and offal
        15
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AE04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Biopharm-Engineering AD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biopharm-Engineering AD
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2173-10.02.2014
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 8/08/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."